Literature DB >> 17539022

A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma.

Kathryn S Poland1, Mohammed Azim, Matthew Folsom, Richard Goldfarb, Rizwan Naeem, Christopher Korch, Harry A Drabkin, Robert M Gemmill, Sharon E Plon.   

Abstract

Studying the molecular basis of familial renal cell carcinoma (RCC) has allowed identification of novel RCC genes involved in the pathogenesis of both inherited and sporadic RCC. We describe a constitutional balanced t(3;8)(p14;q24.1) translocation found in a brother and sister with bilateral clear cell RCC (CC-RCC) diagnosed in their forties. Consistent with a prior report, we demonstrated by RT-PCR of RNA from lymphoblastoid cells fusion mRNAs derived from the fragile histidine triad (FHIT) at 3p14 and TRC8 at 8q24.1 in both affected siblings. Cytogenetic analysis of a CC-RCC tumor from the affected sister from short-term tumor cell culture showed both diploid and pseudotetraploid populations containing the translocation and normal appearing chromosomes 3 and 8. Fluorescent in situ hybridization using bacterial artificial chromosomes containing sequences from the FHIT and TRC8 genes demonstrated normal FHIT signals and TRC8 signals on nontranslocated chromosomes in the constitutional blood sample, but the TRC8 signal was absent in a subset of diploid and pseudotetraploid cells from the tumor. The tumor also contained a heterozygous VHL frameshift somatic mutation. These results confirm that balanced translocations disrupting the TRC8 and FHIT genes result in an increased genetic susceptibility for bilateral CC-RCC. The presence of diploid and tetraploid tumor cells with and without TRC8 deletions on the nontranslocated chromosome suggest that loss of the remaining normal allele of TRC8 may contribute to tumor development at later stages. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17539022     DOI: 10.1002/gcc.20466

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  18 in total

Review 1.  Chromosomal translocations and palindromic AT-rich repeats.

Authors:  Takema Kato; Hiroki Kurahashi; Beverly S Emanuel
Journal:  Curr Opin Genet Dev       Date:  2012-03-06       Impact factor: 5.578

2.  A palindrome-mediated recurrent translocation with 3:1 meiotic nondisjunction: the t(8;22)(q24.13;q11.21).

Authors:  Molly B Sheridan; Takema Kato; Chad Haldeman-Englert; G Reza Jalali; Jeff M Milunsky; Ying Zou; Ruediger Klaes; Georgio Gimelli; Stefania Gimelli; Robert M Gemmill; Harry A Drabkin; April M Hacker; Julia Brown; David Tomkins; Tamim H Shaikh; Hiroki Kurahashi; Elaine H Zackai; Beverly S Emanuel
Journal:  Am J Hum Genet       Date:  2010-07-30       Impact factor: 11.025

3.  Case report: renal cell carcinoma segregating with a t(2;3)(q37.3;q13.2) chromosomal translocation in an Ashkenazi Jewish family.

Authors:  L McKay; M Frydenberg; L Lipton; F Norris; I Winship
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

4.  Lysosomal acid lipase promotes cholesterol ester metabolism and drives clear cell renal cell carcinoma progression.

Authors:  Jun Wang; Mingyue Tan; Jifu Ge; Ping Zhang; Jie Zhong; Le Tao; Qiong Wang; Xuemei Tong; Jianxin Qiu
Journal:  Cell Prolif       Date:  2018-03-23       Impact factor: 6.831

5.  Analysis of the t(3;8) of hereditary renal cell carcinoma: a palindrome-mediated translocation.

Authors:  Takema Kato; Colleen P Franconi; Molly B Sheridan; April M Hacker; Hidehito Inagakai; Thomas W Glover; Martin F Arlt; Harry A Drabkin; Robert M Gemmill; Hiroki Kurahashi; Beverly S Emanuel
Journal:  Cancer Genet       Date:  2014-03-18

6.  Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia.

Authors:  Shinichiro Kawamoto; Katsuya Yamamoto; Masanori Toyoda; Kimikazu Yakushijin; Hiroshi Matsuoka; Hironobu Minami
Journal:  Int J Hematol       Date:  2016-09-29       Impact factor: 2.490

7.  The TRC8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways.

Authors:  Jason P Lee; Anne Brauweiler; Michael Rudolph; Joan E Hooper; Harry A Drabkin; Robert M Gemmill
Journal:  Mol Cancer Res       Date:  2010-01-12       Impact factor: 5.852

8.  Overexpression of ZNF342 by juxtaposition with MPO promoter/enhancer in the novel translocation t(17;19)(q23;q13.32) in pediatric acute myeloid leukemia and analysis of ZNF342 expression in leukemia.

Authors:  Kathryn S Poland; Deborah L Shardy; Mohammed Azim; Rizwan Naeem; Robert A Krance; ZoAnne E Dreyer; E Shannon Neeley; Nianxiang Zhang; Yi Hua Qiu; Steven M Kornblau; Sharon E Plon
Journal:  Genes Chromosomes Cancer       Date:  2009-06       Impact factor: 5.006

9.  The tumor suppressor gene TRC8/RNF139 is disrupted by a constitutional balanced translocation t(8;22)(q24.13;q11.21) in a young girl with dysgerminoma.

Authors:  Stefania Gimelli; Silvana Beri; Harry A Drabkin; Claudio Gambini; Andrea Gregorio; Patrizia Fiorio; Orsetta Zuffardi; Robert M Gemmill; Roberto Giorda; Giorgio Gimelli
Journal:  Mol Cancer       Date:  2009-07-30       Impact factor: 27.401

10.  The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER.

Authors:  Helen R Stagg; Mair Thomas; Dick van den Boomen; Emmanuel J H J Wiertz; Harry A Drabkin; Robert M Gemmill; Paul J Lehner
Journal:  J Cell Biol       Date:  2009-08-31       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.